Mab21l2 | mab-21-like 2
GeneMGI:1346022
Physiological systems
22 / 24 physiological systems tested
8 Significantly impacted by the knock-out
Homeostasis/metabolism Embryo Growth/size/body region Nervous system Vision/eye Behavior/neurological Cardiovascular system Mortality/aging
14 No significant impact
2 Not tested
Data collections
Gene metrics:12Significant phenotypes
2Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| no spontaneous movement | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | heterozygote | E18.5 | N/A * | ||
| abnormal placenta vasculature | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | heterozygote | E15.5 | N/A * | ||
| microphthalmia | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | heterozygote | E15.5 | N/A * | ||
| abnormal neural tube morphology | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | heterozygote | E9.5 | N/A * | ||
| anophthalmia | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | heterozygote | Early adult | N/A * | ||
| abnormal eye morphology | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | heterozygote | Early adult | N/A * | ||
| abnormal placenta morphology | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | heterozygote | E15.5 | N/A * | ||
| embryonic growth retardation | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | heterozygote | E15.5 | N/A * | ||
| prenatal lethality prior to heart atrial septation | 1 supporting dataset | Mab21l2em1(IMPC)Mbp | homozygote | E15.5 | N/A * | ||
| preweaning lethality, complete penetrance | 3 supporting datasets | Mab21l2em1(IMPC)Mbp | homozygote | Early adult | N/A * |
| | | | | | | | | | |
External links
No external links available for Mab21l2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| Mab21l2em1(IMPC)Mbp | Whole-gene deletion | | mouse |